Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence
Clinical trial NCT03052764 · COMPLETED
Trial details
- NCT number
- NCT03052764
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-12
- Primary completion
- 2018-12-10
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.